Scientists have shown in mice that skin cells re-programmed into brain stem cells, transplanted into the central nervous system, help reduce inflammation and may be able to help repair damage caused by multiple sclerosis (MS).
Our mouse study suggests that using a patient’s reprogrammed cells could provide a route to personalised treatment of chronic inflammatory diseases, including progressive forms of MS
The study, led by researchers at the University of Cambridge, is a step towards developing personalised treatments based on a patient’s own skin cells for diseases of the central nervous system (CNS).
In MS, the body’s own immune system attacks and damages myelin, the protective sheath around nerve fibres, causing disruption to messages sent around the brain and spinal cord. Symptoms are unpredictable and include problems with mobility and balance, pain, and severe fatigue.
Key immune cells involved in causing this damage are macrophages (literally ‘big eaters’), which ordinarily serve to attack and rid the body of unwanted intruders. A particular type of macrophage known as microglia are found throughout the brain and spinal cord – in progressive forms of MS, they attack the CNS, causing chronic inflammation and damage to nerve cells.
Recent advances have raised expectations that diseases of the CNS may be improved by the use of stem cell therapies. Stem cells are the body’s ‘master cells’, which can develop into almost any type of cell within the body. Previous work from the Cambridge team has shown that transplanting neural stem cells (NSCs) – stem cells that are part-way to developing into nerve cells – reduces inflammation and can help the injured CNS heal.
However, even if such a therapy could be developed, it would be hindered by the fact that such NSCs are sourced from embryos and therefore cannot be obtained in large enough quantities. Also, there is a risk that the body will see them as an alien invader, triggering an immune response to destroy them.
A possible solution to this problem would be the use of so-called ‘induced neural stem cells (iNSCs)’ – these cells can be generated by taking an adult’s skin cells and ‘re-programming’ them back to become neural stem cells. As these iNSCs would be the patient’s own, they are less likely to trigger an immune response.
Now, in research published in the journal Cell Stem Cell, researchers at the University of Cambridge have shown that iNSCs may be a viable option to repairing some of the damage caused by MS.
Using mice that had been manipulated to develop MS, the researchers discovered that chronic MS leads to significantly increased levels of succinate, a small metabolite that sends signals to macrophages and microglia, tricking them into causing inflammation, but only in cerebrospinal fluid, not in the peripheral blood.
Transplanting NSCs and iNSCs directly into the cerebrospinal fluid reduces the amount of succinate, reprogramming the macrophages and microglia – in essence, turning ‘bad’ immune cells ‘good’. This leads to a decrease in inflammation and subsequent secondary damage to the brain and spinal cord.
“Our mouse study suggests that using a patient’s reprogrammed cells could provide a route to personalised treatment of chronic inflammatory diseases, including progressive forms of MS,” says Dr Stefano Pluchino, lead author of the study from the Department of Clinical Neurosciences at the University of Cambridge.
“This is particularly promising as these cells should be more readily obtainable than conventional neural stem cells and would not carry the risk of an adverse immune response.”
The research team was led by Dr Pluchino, together with Dr Christian Frezza from the MRC Cancer Unit at the University of Cambridge, and brought together researchers from several university departments.
Dr Luca Peruzzotti-Jametti, the first author of the study and a Wellcome Trust Research Training Fellow, says: “We made this discovery by bringing together researchers from diverse fields including regenerative medicine, cancer, mitochondrial biology, inflammation and stroke and cellular reprogramming. Without this multidisciplinary collaboration, many of these insights would not have been possible.”
The Latest on: Personalised stem cell treatment
via Google News
The Latest on: Personalised stem cell treatment
- ‘Bubble Boys’ Cured in Medical Breakthrough Using Gene Therapy on April 17, 2019 at 2:00 pm
In a major scientific breakthrough, researchers at St. Jude Children’s Research Hospital in Memphis have developed a one-time, personalized treatment ... chemotherapy to make room for the new cells. ... […]
- Personalized Cell Therapy Market Growth And Revenue Analysis By 2026 | Cytori Therapeutics, Bellicum Pharmaceuticals, Saneron CCEL Therapeutics on April 17, 2019 at 11:38 am
obtaining adult stem cells is difficult to collect or tough to be expanded in a therapeutically sufficient amount. Some of the major companies in personalized cell therapy market are Cytori ... […]
- Researchers identify a new biomarker for personalised treatments against cancer on April 17, 2019 at 6:30 am
Cancer cells are characterised by the ability ... this study offers a new approach to support physicians in the selection of personalised treatments. "We are now extending the study to other ... […]
- Researchers Create 3D-Printed Heart Using Patient’s Own Cells on April 17, 2019 at 6:23 am
While the cells were reprogrammed to become pluripotent stem cells, the extracellular matrix, a 3D network of extracellular macromolecules such as collagen and glycoproteins, were processed into a ... […]
- New test could lead to personalized treatments for cystic fibrosis on April 17, 2019 at 5:59 am
straightforward way to test multiple drugs on cells obtained from individual patients with cystic fibrosis, raising the possibility of highly personalized drug treatment. The team found that the ... […]
- Computational researchers and oncologists develop protein cancer atlas to accelerate personalized medicine for leukemia patients on April 17, 2019 at 1:08 am
The new protein classifications will help researchers and clinicians recommend better treatment and personalized medicine for ... tested through drug screens and can be ‘programmed’ into cells through ... […]
- Study uncovers new biomarker for personalized cancer treatments on April 16, 2019 at 2:09 pm
Cancer cells are characterized by the ability to evade apoptosis ... In this regard, this study offers a new approach to support physicians in the selection of personalized treatments. "We are now ... […]
- Phenotyping ciliary dynamics and coordination in response to CFTR-modulators in Cystic Fibrosis respiratory epithelial cells on April 16, 2019 at 2:16 am
Firstly, it should now be possible to quantitatively assess a wide range of putative drugs for the treatment of CF in a personalised manner, based on changes in ciliary beating and coordination of the ... […]
- ChemoID® utilizes personalized chemotherapy treatment after testing cells on April 15, 2019 at 12:58 pm
When you or a loved one is diagnosed with cancer, you want the most effective cancer treatment available. Because each cancer is different, the same chemotherapy drug may not work the same way for ... […]
- Cancer: 'Off-the-shelf' stem cell treatment enters clinical trial on April 10, 2019 at 11:32 pm
Many therapies make use of a patient's own cells or cells from a donor. While this type of personalized treatment is the mainstay of current cell therapy applications, it is costly and time-consuming. ... […]
via Bing News